BioSpace News Archive

3Spine, Inc., a U.S. medical device company developing total joint replacement for the lumbar spine, announced the appointment of Pierce Nunley, MD, to the company’s Medical Advisory Board.

MaaT Pharma (EURONEXT: MAAT – the “Company”), today announced completion of its Phase 1b CIMON trial evaluating the safety and tolerability of MaaT033, the Company’s high-richness, high-diversity MET for oral administration, in patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (HRMS) having received intensive chemotherapy.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the acceptance of seven key oncology research abstracts authored in collaboration with Illumina at the American Society of Clinical Oncology (ASCO) annual meeting taking place June 3 – June 7 in Chicago.

The study was carried out by Dr. Massimo Nabissi from the School of Pharmacy Section of Experimental Medicine, University of Camerino in Camerino, Italy.

Biopharmaceutical company promotes Jennifer Lee to senior vice president of clinical operations, data management and biostatistics.

Boyden Gray & Associates PLLC -- Today, a group of doctors filed a lawsuit against the Department of Health and Human Services, Xavier Becerra in his official capacity as Secretary of Health and Human Services, the Food and Drug Administration, and Robert M. Califf in his official capacity as Commissioner of Food and Administration.

Cingulate Inc. announced that Chairman and CEO Shane J. Schaffer, PharmD, and preeminent board-certified psychiatrist and Cingulate scientific advisor Dr. Ann Childress, MD, will participate in a live Benzinga All Access event on June 3, 2022, at 8:45 a.m. CST.

Leaders from the American College of Surgeons called for bipartisan solutions to reduce the rising numbers of deaths and serious injuries that are arriving in trauma centers on a daily basis due to firearm violence.

Novotech, the leading Asia Pacific biotech specialist CRO with recently expanded services to the US, sponsored expert panels at the Pre-ASCO China Summit 2022, bringing together leaders in oncology drug development in China and the US.

RxBIO, a medical device distributor based in Toronto, CA, gains exclusivity to sell the NeoGen Plasma Skin Rejuvenation System into Iowa, Minnesota and Utah, as well as securing rights in Michigan, Illinois and Kansas.